معرفی
Dr. Amjad Khan is a Senior Honorary Fellow at the University of Oxford, affiliated with the Kerr and Pezzella Group: Colorectal Clinical and Pathology Group. His research focuses on molecular mechanisms of cancer development, biomarker identification for early diagnosis, and therapeutic intervention mechanisms through integrative biochemistry and genomics approaches. Collaborators include Prof. David Kerr (Oxford), Paul Brennan (IARC, France), and Prof. Dean Harris (Swansea University).
Education: Postdoc (Oxford), DPhil (Oxford), M.Sc (Oxford).
Research interests emphasize translating biochemical and genomic insights into clinical applications, with a multidisciplinary approach involving experimental medicine and clinical studies.
No specific articles or awards listed, but he actively mentors prospective PhD candidates in cancer research focusing on biomarkers and therapeutic mechanisms.
Participates in collaborative teams such as the Kerr and Pezzella Group, driving interdisciplinary cancer research initiatives.
